Corcept Therapeutics | CORT - Stock


Corcept Therapeutics reported $12.89M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Canopy Growth CAD 105.56M 3.18M Dec/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Esperion Therapeutics USD 104.21M 915K Mar/2026
J&J USD 14.58B 392M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Merck USD 6.48B 179M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.29B 17M Mar/2026
Novartis USD 6.42B 114M Sep/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 150.37M 2.49M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
TG Therapeutics USD 129.03M 3.44M Mar/2026